Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: End-of-s...

by Einstein, Mark H, Takacs, Peter, Chatterjee, Archana, Sperling, Rhoda S, Chakhtoura, Nahida, Blatter, Mark M, Lalezari, Jacob, David, Marie-Pierre, Lin, Lan, Struyf, Frank, Dubin, Gary
Published 2014

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

by Pavia-Ruz, Noris, Angel Rodriguez Weber, Miguel, Lau, Yu-Lung, Nelson, E Anthony S, Kerdpanich, Angkool, Huang, Li-Min, Silas, Peter, Qaqundah, Paul, Blatter, Mark, Jeanfreau, Robert, Lei, Paul, Jain, Varsha, El Idrissi, Mohamed, Feng, Yang, Innis, Bruce, Peeters, Mathieu, Devaster, Jeanne-Marie
Published 2013

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial

by Ramanakumar, Agnihotram V, Naud, Paulo, Roteli-Martins, Cecilia M, de Carvalho, Newton S, de Borba, Paola C, Teixeira, Julio C, Blatter, Mark, Moscicki, Anna-Barbara, Harper, Diane M, Romanowski, Barbara, Tyring, Stephen K, Ramjattan, Brian, Schuind, Anne, Dubin, Gary, Franco, Eduardo L
Published 2016